{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T15:36:15Z","timestamp":1773502575374,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09508-3","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T13:02:36Z","timestamp":1714050156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mutational spectrum of CFTR in cystic fibrosis patients with gastrointestinal and hepatobiliary manifestations"],"prefix":"10.1007","volume":"51","author":[{"given":"Nadia","family":"Waheed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehmana","family":"Waris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Naseer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Razzaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nighat","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abid Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmat","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"issue":"4","key":"9508_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5223\/pghn.2018.21.4.306","volume":"21","author":"ALM Dos Santos","year":"2018","unstructured":"Dos Santos ALM et al (2018) Cystic fibrosis: clinical phenotypes in children and adolescents. Pediatr Gastroenterol Hepatol Nutr 21(4):306\u2013314","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"4","key":"9508_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jcf.2016.02.002","volume":"15","author":"A Munck","year":"2016","unstructured":"Munck A et al (2016) International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome. J Cyst Fibros 15(4):531\u2013539","journal-title":"J Cyst Fibros"},{"issue":"5","key":"9508_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jped.2017.07.006","volume":"94","author":"FS Nascimento","year":"2018","unstructured":"Nascimento FS et al (2018) Hepatobiliary disease in children and adolescents with cystic fibrosis. J Pediatr (Rio J) 94(5):504\u2013510","journal-title":"J Pediatr (Rio J)"},{"issue":"10290","key":"9508_CR4","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","volume":"397","author":"M Shteinberg","year":"2021","unstructured":"Shteinberg M et al (2021) Cystic fibrosis. Lancet 397(10290):2195\u20132211","journal-title":"Lancet"},{"issue":"1","key":"9508_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0888-7543(91)90503-7","volume":"10","author":"J Zielenski","year":"1991","unstructured":"Zielenski J et al (1991) Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 10(1):214\u2013228","journal-title":"Genomics"},{"issue":"3","key":"9508_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ame2.12180","volume":"4","author":"Q Chen","year":"2021","unstructured":"Chen Q, Shen Y, Zheng J (2021) A review of cystic fibrosis: Basic and clinical aspects. Anim Model Exp Med 4(3):220\u2013232","journal-title":"Anim Model Exp Med"},{"issue":"1","key":"9508_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12881-020-0958-9","volume":"21","author":"S Chamayou","year":"2020","unstructured":"Chamayou S et al (2020) The true panel of cystic fibrosis mutations in the sicilian population. BMC Med Genet 21(1):89","journal-title":"BMC Med Genet"},{"issue":"5","key":"9508_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/17476348.2018.1457438","volume":"12","author":"A Bergougnoux","year":"2018","unstructured":"Bergougnoux A et al (2018) Current and future molecular approaches in the diagnosis of cystic fibrosis. Expert Rev Respir Med 12(5):415\u2013426","journal-title":"Expert Rev Respir Med"},{"issue":"5","key":"9508_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1365-3156.2009.02253.x","volume":"14","author":"U Shah","year":"2009","unstructured":"Shah U, Frossard P, Moatter T (2009) Cystic fibrosis: defining a disease under-diagnosed in Pakistan. Tropical Med Int Health 14(5):542\u2013545","journal-title":"Tropical Med Int Health"},{"issue":"R2","key":"9508_CR10","doi-asserted-by":"publisher","first-page":"R173","DOI":"10.1093\/hmg\/ddy188","volume":"27","author":"LJ Strug","year":"2018","unstructured":"Strug LJ et al (2018) Recent advances in developing therapeutics for cystic fibrosis. Hum Mol Genet 27(R2):R173\u2013R186","journal-title":"Hum Mol Genet"},{"issue":"7","key":"9508_CR11","first-page":"217","volume":"50","author":"ZA Bhutta","year":"2000","unstructured":"Bhutta ZA, Moattar T, Shah U (2000) Genetic analysis of cystic fibrosis in Pakistan: a preliminary report. J Pak Med Assoc 50(7):217\u2013219","journal-title":"J Pak Med Assoc"},{"issue":"3","key":"9508_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jcf.2008.03.009","volume":"7","author":"C Castellani","year":"2008","unstructured":"Castellani C et al (2008) Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 7(3):179\u2013196","journal-title":"J Cyst Fibros"},{"issue":"10","key":"9508_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/sj.ejhg.5200850","volume":"10","author":"J McCormick","year":"2002","unstructured":"McCormick J et al (2002) Demographics of the UK cystic fibrosis population: implications for neonatal screening. Eur J Hum Genet 10(10):583\u2013590","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"9508_CR14","first-page":"e54627","volume":"16","author":"S Yavuz","year":"2024","unstructured":"Yavuz S et al (2024) A unique mutation in the cystic fibrosis transmembrane Conductance Regulator (CFTR) gene causing cystic fibrosis in a Pakistani child: a Case highlighting the need for more awareness. Cureus 16(2):e54627","journal-title":"Cureus"},{"issue":"2","key":"9508_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00251-022-01278-1","volume":"75","author":"N Waheed","year":"2023","unstructured":"Waheed N et al (2023) Whole exome sequencing identified a novel splice donor site variant in interleukin 2 receptor alpha chain. Immunogenetics 75(2):71\u201379","journal-title":"Immunogenetics"},{"issue":"5","key":"9508_CR16","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Sci 17(5):405\u2013423","journal-title":"Genet Sci"},{"issue":"6","key":"9508_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","volume":"136","author":"PD Stenson","year":"2017","unstructured":"Stenson PD et al (2017) The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 136(6):665\u2013677","journal-title":"Hum Genet"},{"key":"9508_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biocel.2014.04.001","volume":"52","author":"Y Wang","year":"2014","unstructured":"Wang Y, Wrennall JA, Cai Z, Li H, Sheppard DN (2014) Understanding how cystic fibrosis mutations disrupt CFTR function: from single molecules to animal models. Int J Biochem Cell Biol 52:47\u201357","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"9508_CR19","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1152\/physrev.1999.79.1.S23","volume":"79","author":"DN SHEPPARD","year":"1999","unstructured":"SHEPPARD DN (1999) Structure and function of the CFTR Chloride Channel. Physiol Rev 79(1):S23\u2013S45","journal-title":"Physiol Rev"},{"key":"9508_CR20","doi-asserted-by":"crossref","unstructured":"Harvey C et al (2022) The effect of CFTR modulators on Airway Infection in cystic fibrosis. Int J Mol Sci, 23(7)","DOI":"10.3390\/ijms23073513"},{"issue":"2","key":"9508_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.0.CO;2-J","volume":"10","author":"X Estivill","year":"1997","unstructured":"Estivill X, Bancells C, Ramos C (1997) Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat 10(2):135\u2013154","journal-title":"Hum Mutat"},{"issue":"7","key":"9508_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1136\/adc.2003.042614","volume":"90","author":"M Mei-Zahav","year":"2005","unstructured":"Mei-Zahav M et al (2005) The prevalence and clinical characteristics of cystic fibrosis in south Asian Canadian immigrants. Arch Dis Child 90(7):675","journal-title":"Arch Dis Child"},{"issue":"3","key":"9508_CR23","first-page":"554","volume":"33","author":"DA Aziz","year":"2017","unstructured":"Aziz DA et al (2017) Clinical and laboratory profile of children with cystic fibrosis: experience of a tertiary care center in Pakistan. Pak J Med Sci 33(3):554\u2013559","journal-title":"Pak J Med Sci"},{"issue":"2","key":"9508_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/jmg.30.2.164","volume":"30","author":"A Curtis","year":"1993","unstructured":"Curtis A et al (1993) Absence of cystic fibrosis mutations in a large Asian population sample and occurrence of a homozygous S549N mutation in an inbred Pakistani family. J Med Genet 30(2):164\u2013166","journal-title":"J Med Genet"},{"key":"9508_CR25","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","volume":"10","author":"M Lopes-Pacheco","year":"2019","unstructured":"Lopes-Pacheco M (2019) CFTR modulators: the changing Face of cystic fibrosis in the era of Precision Medicine. Front Pharmacol 10:1662","journal-title":"Front Pharmacol"},{"key":"9508_CR26","doi-asserted-by":"crossref","unstructured":"Hosseini Nami A et al (2023) Genetic attributes of Iranian cystic fibrosis patients: the diagnostic efficiency of CFTR mutations in over a decade. Front Genet, 14","DOI":"10.3389\/fgene.2023.1140034"},{"key":"9508_CR27","unstructured":"Orenti et al (2023) European Cystic Fibrosis Society, Annual Report 2021"},{"issue":"2","key":"9508_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jcf.2007.06.004","volume":"7","author":"SS Shastri","year":"2008","unstructured":"Shastri SS et al (2008) Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India. J Cyst Fibros 7(2):110\u2013115","journal-title":"J Cyst Fibros"},{"key":"9508_CR29","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/S1569-1993(23)00403-4","volume":"22","author":"A Safdar","year":"2023","unstructured":"Safdar A et al (2023) P027 mutational analysis of CFTR gene in Pakistani cystic fibrosis patients. J Cyst Fibros 22:S71\u2013S72","journal-title":"J Cyst Fibros"},{"issue":"6","key":"9508_CR30","doi-asserted-by":"publisher","first-page":"p1005","DOI":"10.1007\/s12041-017-0868-6","volume":"96","author":"M Umair","year":"2017","unstructured":"Umair Met a. (2017) Ellis-Van Creveld syndrome and profound deafness resulted by sequence variants in the EVC\/EVC2 and TMC1 genes. J Genet 96(6):p1005\u20131014","journal-title":"J Genet"},{"key":"9508_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3601","author":"W Akbar","year":"2023","unstructured":"Akbar W et al (2023) Identification of novel homozygous variants in FOXE3 and AP4M1 underlying congenital syndromic anophthalmia and microphthalmia. J Gene Med. https:\/\/doi.org\/10.1002\/jgm.3601","journal-title":"J Gene Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09508-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09508-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09508-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:25:36Z","timestamp":1738700736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09508-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9508"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09508-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"27 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"All experimental protocols involving humans were approved by the Institutional Ethical Review Committee of the Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of data generated in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work the authors have not used any AI tool\/s and have prepared the content themselves as needed and take\u00a0(s) full responsibility for the content of the publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of AI in scientific writing"}}],"article-number":"573"}}